Indian drug for dementia gets US regulatory nod

0 Comments

Indian drug-maker Strides Shasun Ltd has got approval of the US regulator for its Memantine Hydrochloride tablets to treat Alzheimer's-type dementia, said the company on Wednesday. In a regultory filing on the BSE, the city-based company said the US Food & Drug Administration (USFDA) has approved its 5mg and 10mg Memantine Hydrochloride tablets for treating moderate to severe Alzheimer's-type dementia. "The US market for Memantine Hydrochloride tablets is about $60 million. The product will be manufactured at our flagship facility in Bengaluru and marketed by Strides Pharma Inc in the US at the earliest,".

Get profit from the Financial Market with lots of profitable service packages and more click here--- http://www.ripplesadvisory.com/nifty-future-.php

Ripples Advisory Private Limited

Ripples Advisory is a SEBI Registered & ISO Certified Share Market Advisory. It is undoubtedly the Best Nifty Tips Provider in India. Ripples Advisory private limited is, without doubt, the only advisory firm which has repute in providing Nifty Market Tips & other share market tips. Ripples Advisory has a team of experienced & skilled research analyst who provide sure shot share market tips which has helped its clients to earn a huge amount of profit from their investments. Get the most accurate Nifty Future Trading Tips, Nifty Market Tips, Nifty Future Tips On Mobile, etc only at Ripples Advisory. To know more about Ripples Advisory & it's services, visit - http://www.ripplesadvisory.com/nifty-future.php or give us a missed call at - 9644405056

No comments:

Post a Comment

Note: only a member of this blog may post a comment.